Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 40 Records) |
| Query Trace: Lung Neoplasms and NAT2[original query] |
|---|
| A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer. Neoplasma 2005 52 (5): 364-8. Habalová V, Salagovic J, Kalina I, Stubna |
| NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan. Cancer letters 2005 Jun 223 (1): 93-101. Chiou Hui-Ling, Wu Ming-Fang, Chien Wen-Pin, Cheng Ya-Wen, Wong Ruey-Hong, Chen Chin-Yi, Lin Torng-Sen, Lee Hu |
| Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung cancer (Amsterdam, Netherlands) 2005 May 48 (2): 187-99. Skuladottir Halla, Autrup Herman, Autrup Judith, Tjoenneland Anne, Overvad Kim, Ryberg David, Haugen Aage, Olsen Jørgen |
| N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. BMC medical genetics 2006 7 (): 58. Borlak Juergen, Reamon-Buettner Stella Mar |
| Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China. Disease markers 2006 22 (3): 141-52. Chen Han-chun, Cao Yan-fei, Hu Wei-xin, Liu Xin-fa, Liu Qing-xia, Zhang Ji, Liu J |
| Cancer and molecular biomarkers of phase 2. Methods in enzymology 2006 1 400 618-27. Dalhoff Kim, Buus Jensen Kaspar, Enghusen Poulsen Henr |
| NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. Asian Pacific journal of cancer prevention : APJCP 0 8 (1): 103-8. Osawa Yasunori, Osawa Kayo Kumar, Miyaishi Aiko, Higuchi Miho, Tsutou Akimitsu, Matsumura Sueo, Tabuchi Yoshiki, Tsubota Noriaki, Takahashi Ju |
| Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer. Bulletin of experimental biology and medicine 2007 Jan 143 (1): 83-6. Nikishina M V, Vavilin V A, Makarova S I, Lyakhovich V |
| Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 2007 Jun 28 (6): 1287-93. Gemignani Federica, Landi Stefano, Szeszenia-Dabrowska Neonilia, Zaridze David, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Foretova Lenka, Janout Vladimir, Bencko Vladimir, Gaborieau Valérie, Gioia-Patricola Lydie, Bellini Ilaria, Barale Roberto, Canzian Federico, Hall Janet, Boffetta Paolo, Hung Rayjean J, Brennan Pa |
| NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan. Lung cancer (Amsterdam, Netherlands) 2009 Apr 64 (1): 9-12. Lee Chun-Nin, Yu Ming-Chih, Bai Kuan-Jen, Chang Jer-Hua, Fang Chia-Lang, Hsu Han-Lin, Huang Biing-Shiung, Lu Pei-Chih, Liu H Euge |
| A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 2008 Jun 29 (6): 1164-9. Zienolddiny Shanbeh, Campa Daniele, Lind Helge, Ryberg David, Skaug Vidar, Stangeland Lodve B, Canzian Federico, Haugen Aa |
| Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Jan 17 (1): 141-7. McKay James D, Hashibe Mia, Hung Rayjean J, Wakefield Jon, Gaborieau Valerie, Szeszenia-Dabrowska Neonila, Zaridze David, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Foretova Lenka, Janout Vladimir, Bencko Vladimir, Chabrier Amelie, Hall Janet, Boffetta Paolo, Canzian Federico, Brennan Pa |
| Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. DNA and cell biology 2009 Sep 28 (9): 443-9. Sobti Ranbir C, Kaur Pushpinder, Kaur Satinder, Janmeja Ashok K, Jindal Surinder K, Kishan Jai, Raimondi Sa |
| GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. Anticancer research 2009 May 29 (5): 1709-14. Zupa Angela, Sgambato Alessandro, Bianchino Gabriella, Improta Giuseppina, Grieco Vitina, LA Torre Giuseppe, Campisi Biagina, Traficante Antonio, Aieta Michele, Cittadini Achil |
| Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jun 19 (6): 1492-7. Lee Mi-Sun, Su Li, Christiani David |
| Additional candidates to conventional genes susceptible for lung cancer and changing trend in Japan. Oncology reports 2010 Jun 23 (6): 1493-500. Okazaki Isao, Sugita Minoru, Matsuki Hideaki, Billah Syed Muhammad Baqui, Watanabe Tet |
| Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells. Carcinogenesis 2010 Dec 31 (12): 2091-6. Lee Mi-Sun, Su Li, Mark Eugene J, Wain John C, Christiani David |
| NAT2 polymorphism and lung cancer risk: a meta-analysis. Lung cancer (Amsterdam, Netherlands) 2011 Aug 73 (2): 153-7. Cui Dan, Wang Zhanwei, Zhao Erjiang, Ma Jie, Lu Weiqu |
| Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer. The Journal of surgical research 2011 May 167 (1): e5-12. Campayo Marc, Viñolas Nuria, Navarro Alfons, Carcereny Enric, Casas Francesc, Gel Bernat, Diaz Tania, Gimferrer Josep Maria, Marrades Ramon M, Ramirez Jose, Monzo Maria |
| [Polymorphism in the N-acetyltransferase 2 gene in patients with lung cancer. Short communication]. Pneumonologia i alergologia polska 2012 80 (4): 323-8. Zabost Anna, Roszkowska-?li? Barbara, Wiatr El?bieta, Radzikowska El?bieta, Rogala Ewa, Zych Jacek, Zwolska Zofia, Augustynowicz-Kope? Ewa, Roszkowski-?li? Kazimierz, Szczepulska-Wójcik E |
| Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer. Genetics and molecular biology 2012 Dec 35 (4): 4. Mahasneh A, Jubaili A, El Bateiha A, Al-Ghazo M, Matalka I, Malkawi M |
| N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males. Medical oncology (Northwood, London, England) 2014 Aug 31 (8): 90. Tian Fangshuo, Zhang Yue, Ren Yangwu, Shen Li, Wu Wei, Zhou Baos |
| Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region. Asian Pacific journal of cancer prevention : APJCP 2014 15 (21): 9203-10. Zhang Jing-Wen, Yu Wan-Jia, Sheng Xiao-Min, Chang Fu-Hou, Bai Tu-Ya, Lv Xiao-Li, Wang Guang, Liu Su-Zh |
| Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. Journal of cancer research and clinical oncology 2015 May 141 (5): 851-60. Mota P, Silva H C, Soares M J, Pego A, Loureiro M, Cordeiro C Robalo, Regateiro F |
| [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers]. Radiatsionnaia biologiia, radioecologiia / Rossi?skaia akademiia nauk 0 54 (4): 350-9. Rusinova G G, Azizova T V, Viazovskaia N S, Glazkova I V, Gur'ianov M Iu, Osovets S |
| Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility. Medicine 2015 Dec 94 (49): e1947. Liu Chang, Cui Wei, Cong Lin, Wang Li, Ruan Xinjian, Jia Jia, Liu Yanfang, Jia Xiaoyan, Zhang X |
| Influence of N-acetyltransferase 2 gene polymorphisms on the in vitro metabolism of the epidermal growth factor receptor inhibitor rociletinib. British journal of clinical pharmacology 2021 Apr . Ramirez Jacqueline, House Larry K, Ratain Mark |
| Association Between NAT2 Polymorphism and Lung Cancer Risk: A Systematic Review and Meta-Analysis. Frontiers in oncology 2021 11 567762. Zhu Ke, Xu Aiqun, Xia Wanli, Li Pulin, Zhang Binbin, Jiang Huihui, Zhou Sijing, Wang R |
| Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy. Xenobiotica; the fate of foreign compounds in biological systems 2022 4 52 (3): 322-331. Walia Harleen, Sharma Parul, Singh Navneet, Sharma Siddhar |
| Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians. International journal of environmental health research 2022 Oct 1-24. Walia Harleen Kaur, Sharma Parul, Singh Navneet, Sharma Siddhar |
- Page last reviewed:Feb 1, 2024
- Content source: